Bayer HealthCare And Covance Form Strategic Partnership
May 30 2012 - 3:17AM
Dow Jones News
German pharmaceutical company Bayer AG (BAYN.XE) Wednesday said
its HealthCare unit has entered into a long-term strategic
partnership with U.S. drug development services company Covance
Inc. (CVD).
MAIN FACTS:
-Bayer and Covance will work on clinical drug development,
including research and development related to Phase II-IV clinical
studies and central laboratory services.
-Bayer said it wants to leverage Covance's experience and
services in R&D to improve its operational delivery, efficiency
and quality.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500